Dopson Pharma (India) Limited

Sells shares, incorporated in 1982, based in Mumbai, Maharashtra.

1982 | Mumbai, Maharashtra (India) | Active
Last Updated:

Dopson Pharma (India) Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 42 Year, 11 Months
  • Last Filing with ROC 31 Mar 2018
  • Satisfied Charges ₹ 9.13 M
  • Revenue Growth %
  • Profit Growth -54416.71%
  • Ebitda -54416.71%
  • Net Worth -99.95%
  • Total Assets -99.95%

About Dopson Pharma (India)

Dopson Pharma (India) Limited (DPIL) is a Public Limited Indian Non-Government Company incorporated in India on 19 March 1982 and has a history of 42 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Financial Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.00 Cr.

The company has closed loans amounting to ₹9.13 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Chetan Palikar, Kuldeep Agrawal, and Anil Mangal serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U99999MH1982PLC026712

  • Company No.

    026712

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    19 Mar 1982

  • Date of AGM

    30 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Financial Services
Company report

Dopson Pharma (India) Limited

Explore comprehensive data for Dopson Pharma (India) Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Dopson Pharma (India)?

Board Members (3)

NameDesignationAppointment DateStatus
Anil Mangal Country flag representing In Additional Director 20-Apr-2017Current
Chetan Palikar Country flag representing In Additional Director 20-Mar-2020Current
Kuldeep Agrawal Country flag representing In Director 29-Jun-2011Current

Financial Performance of Dopson Pharma (India).

Dopson Pharma (India) Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 54416.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.95%.

Dopson Pharma (India) revenue growth over time
Dopson Pharma (India) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-99.95%
Profit or Loss
-54416.71%
Net Worth
-99.95%
EBITDA
-54416.71%

What is the Ownership and Shareholding Structure of Dopson Pharma (India)?

In 2018, Dopson Pharma (India) had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹0.91 Cr

Charges Breakdown by Lending Institutions

  • Corporation Bank : 0.85 Cr
  • Canara Bank : 0.06 Cr

Latest Charge Details

DateLenderAmountStatus
09 Mar 2000Corporation Bank₹8.50 MSatisfied
10 Mar 1986Canara Bank₹0.18 MSatisfied
10 Mar 1983Canara Bank₹0.30 MSatisfied
15 Oct 1982Canara Bank₹0.15 MSatisfied

How Many Employees Work at Dopson Pharma (India)?

Unlock and access historical data on people associated with Dopson Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Dopson Pharma (India) Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dopson Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dopson Pharma (India)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dopson Pharma (India)

Recent activity within the organization

  • Director Appointment

    Chetan Vinod Palikar was appointed as a Additional Director was appointed as a Additional Director on 20 Mar 2020 & has been associated with this company since 4 years 11 months .

  • Annual General Meeting

    Dopson Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.

  • Balance Sheet

    Dopson Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai.

  • Director Appointment

    Anil Mangal was appointed as a Additional Director was appointed as a Additional Director on 20 Apr 2017 & has been associated with this company since 7 years 10 months .

  • Director Appointment

    Kuldeep Agrawal was appointed as a Director was appointed as a Director on 29 Jun 2011 & has been associated with this company since 13 years 8 months .

  • Charges

    A charge registered on 09 Mar 2000 via Charge ID 90364399 with Corporation Bank was fully satisfied on 14 Oct 2005.

Frequently asked questions

  • What is the Incorporation or founding date of Dopson Pharma (India) Limited?

    Dopson Pharma (India) Limited was incorporated on 19 Mar 1982.

  • What is authorized share capital and paid-up capital of Dopson Pharma (India) Limited?

    The authorized share capital of Dopson Pharma (India) Limited is ₹ 10.00 Cr and paid-up capital is ₹ 6.00 Cr.

  • Who are the current board members & directors of Dopson Pharma (India) Limited?

    Currently 3 directors are associated with Dopson Pharma (India) Limited.

    • Chetan Vinod Palikar
    • Kuldeep Agrawal
    • Anil Mangal

  • What is the registered address of Dopson Pharma (India) Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Dopson Pharma (India) Limited is G5/701 Garden Crest Chs Ltd., West Avenue Santacruz India, Mumbai, Maharashtra, 400054.

  • What is the corporate identification number (CIN) and company number of Dopson Pharma (India) Limited?

    The corporate identification number (CIN) of Dopson Pharma (India) Limited is U99999MH1982PLC026712 and the company number is 026712 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Dopson Pharma (India) Limited, and by what percentage?

    The financial reports for the fiscal year 2018 indicates that The net worth of Dopson Pharma (India) Limited has experienced an downturn of -99.95%.

  • When was the last Balance Sheet of Dopson Pharma (India) Limited filed with the ROC?

    The most recent Balance Sheet for Dopson Pharma (India) Limited was filed with the ROC on 31 Mar 2018.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed